Elsevier and SolveBio announce collaboration to accelerate precision medicine research
SolveBio and Elsevier have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated pathways. The SolveBio platform will provide customers with a single seamless solution to drive faster and more accurate research into precision medicine.
Under the terms of the agreement, all licensed SolveBio users will have free access to Pathway Studio’s Pathway Viewer software, an application that enables researchers to quickly view a snapshot of the functional relationships among genes imported for SolveBio. In addition, researchers are able to find top scoring, manually curated pathways that correlate most highly with these genes. Both analyses take only minutes, saving researchers significant time, and delivering access to a growing database of published literature.
‘As the volume of published literature continues to grow, researchers are challenged to uncover all relevant evidence from the available data. This is particularly important for clinical researchers making evidence-based decisions. Our goal is to ensure our customers can quickly find relevant, accurate and trusted data – helping them make confident and informed precision medicine decisions,’ said Jaqui Hodgkinson, vce president of product development, Biology Products, Elsevier. ‘Our collaboration with SolveBio addresses this need by allowing researchers to find more relevant literature-based information. By seamlessly connecting in-house solutions to Pathway Studio’s molecular interaction database, researchers will have an increased understanding of biological findings, supporting more successful outcomes.’
SolveBio enables biopharma customers to leverage molecular information for therapeutic development by unifying and connecting data across their organisation so that scientists can run analytics and answer questions in real-time based on harmonised internal and external data. SolveBio catalogues data as biological entities, like variants, genes, and gene expression profiles, creating a centralised cloud-based inventory of all the biological components in your data layer.
SolveBio’s graphical interface allows researchers in your organization to find the right data at the right time to directly run analytics on all the data to answer mission-critical questions. SolveBio’s RESTful API brings unified, enriched data to downstream applications for analytics and visualization. ‘We’re excited about the integration with Pathway Studio from Elsevier, as it allows SolveBio users to tap into another advanced database of molecular data, instantly broadening the scope of their research,’ said SolveBio CEO Mark Kaganovich.